Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Isabelle Bence-Bruckler"'
Autor:
Neil Berinstein, Isabelle Bence-Bruckler, Nick Forward, Pierre Laneuville, Joy Mangel, Douglas Stewart, Irina Amitai, Gail Klein, Nancy Pennell, Iran Rashedi, Kim Roos, Yogesh Bramhecha, Rebekah Conlon
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/f039d1bd4f604020b83edf07d61f8ced
Autor:
Irina Amitai, Kim Roos, Iran Rashedi, Yidi Jiang, Kathryn Mangoff, Gail Klein, Nicholas Forward, Douglas Stewart, Pierre Laneuville, Isabelle Bence‐Bruckler, Joy Mangel, George Tomlinson, Neil L. Berinstein
Publikováno v:
European Journal of Haematology.
Autor:
Igor Novitzky-Basso, Elena Liew, Eshetu G. Atenafu, Lambert Busque, Pierre Laneuville, Kristjan Paulson, Dennis Dong Hwan Kim, Mary-Margaret Keating, Isabelle Bence-Bruckler, Robert Delage, Suzanne Kamel-Reid, Tracy Stockley, Jeffrey H. Lipton, Donna L. Forrest, Brian Leber, Taehyung S Kim, Lynn Savoie, Anargyros Xenocostas
Publikováno v:
British Journal of Haematology. 193:779-791
Although total duration of tyrosine kinase inhibitor (TKI) therapy and of molecular response at 4 log reduction or deeper (MR4) correlates with treatment-free remission (TFR) success after TKI discontinuation, the optimal cut-off values of the durati
Autor:
Ruth Pettengell, Ariane Boumendil, Joanna Romejko-Jarosinska, R Johnson, Peter Dreger, Stephen P. Robinson, Alejandro Martín, Eva Kimby, N. Schmitz, P Giri, Carsten Utoft Niemann, Anthony H. Goldstone, Isabelle Bence-Bruckler, Bernd Metzner, Silvia Montoto, Ruzena Uddin
Publikováno v:
Bone Marrow Transplantation. 56:1413-1421
We report the 12-year follow-up of the prospective randomized EBMT LYM1 trial to determine whether the benefit of brief duration rituximab maintenance (RM) on progression-free survival (PFS) in patients with relapsed follicular lymphoma (FL) receivin
Autor:
Alex F. Herrera, Stephen M. Ansell, Pier Luigi Zinzani, John Radford, Kami J. Maddocks, Antonio Pinto, Graham P. Collins, Veronika Bachanova, Nancy L. Bartlett, Isabelle Bence-Bruckler, Mehdi Hamadani, Justin Kline, Jiri Mayer, Kerry J. Savage, Ranjana H. Advani, Paolo F. Caimi, René-Olivier Casasnovas, Tatyana A. Feldman, Brian T. Hess, Mariana Bastos-Oreiro, Sunil Iyengar, Árpád Szomor, William Townsend, Marc Andre, Jerzy Dyczkowski, Sandy Eisen, Andrzej Urban, Serafino Pantano, Hans G. Cruz, Luqiang Wang, Yanina Negievich, Jens Wuerthner, Carmelo Carlo-Stella
Publikováno v:
Blood, Vol. 140, no.Supplement 1, p. 3673-3677 (2022)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82a5704fe6c92684e9f9cb8e7a27024b
https://hdl.handle.net/2078.1/274296
https://hdl.handle.net/2078.1/274296
Autor:
Rajiv Samant, Mohammad Jay, Xin Yan Fan, Isabelle Bence-Bruckler, Hina Chaudry, David. A. MacDonald, Jiheon Song, Vimoj Nair
Publikováno v:
Supportive Care in Cancer. 28:5363-5369
Primary central nervous system lymphoma (PCNSL) is a very rare type of malignancy with a poor prognosis. The role of whole brain radiotherapy (WBRT) in PCNSL has been questioned due to the significant neurotoxicity and lack of convincing data for sur
Autor:
Carmelo Carlo-Stella, Stephen Ansell, Pier Luigi Zinzani, John Radford, Kami Maddocks, Antonio Pinto, Graham P. Collins, Veronika Bachanova, Nancy Bartlett, Isabelle Bence-Bruckler, Mehdi Hamadani, Justin Kline, Jiri Mayer, Kerry J. Savage, Ranjana Advani, Paolo Caimi, René-Olivier Casasnovas, Tatyana Feldman, Brian Hess, Mariana Bastos-Oreiro, Sunil Iyengar, Sandy Eisen, Yanina Negievich, Luqiang Wang, Jens Wuerthner, Alex F. Herrera
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S118
Autor:
Carmelo Carlo-Stella, Stephen Ansell, Pier Luigi Zinzani, John Radford, Kami Maddocks, Antonio Pinto, Graham P. Collins, Veronika Bachanova, Nancy Bartlett, Isabelle Bence-Bruckler, Mehdi Hamadani, Justin Kline, Jiri Mayer, Kerry J. Savage, Ranjana Advani, Paolo Calmi, René-Olivier Casasnovas, Tatyana Feldman, Brian Hess, Mariana Bastos-Oreiro, Sunil Iyengar, Sandy Eisen, Yanina Negievich, Luqiang Wang, Jens Wuerthner, Alex F. Herrera
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S347
Autor:
Carmelo Carlo-Stella, Stephen Ansell, Pier Luigi Zinzani, John Radford, Kami Maddocks, Antonio Pinto, Graham P. Collins, Veronika Bachanova, Nancy Bartlett, Isabelle Bence-Bruckler, Mehdi Hamadani, Justin Kline, Jiri Mayer, Kerry J. Savage, Ranjana Advani, Paolo Caimi, René-Olivier Casasnovas, Tatyana Feldman, Brian Hess, Mariana Bastos-Oreiro, Sunil Iyengar, Sandy Eisen, Yanina Negievich, Luqiang Wang, Jens Wuerthner, Alex F. Herrera
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S162
Autor:
Dennis Dong Hwan Kim, Lambert Busque, Suzanne Kamel-Reid, Elena Liew, Anargyros Xenocostas, Igor Novitzky Basso, Mary-Margaret Keating, Lynn Savoie, Taehyung Simon Kim, Brian Leber, Tracy Stockley, Robert Delage, Donna L. Forrest, Pierre Laneuville, Kristjan Paulson, Jeffrey H. Lipton, Isabelle Bence-Bruckler, Eshetu G. Atenafu
Publikováno v:
British journal of haematologyReferences. 196(1)
The doubling time (DT) of the BCR-ABL1 quantitative polymerase chain reaction (qPCR) transcript level reflects the re-growing fraction of leukaemic cells after discontinuation of tyrosine kinase inhibitor (TKI). The present study analyzed monthly DT